Autonomic Control of the Circulation and VDR

Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age21-35
SponsorMilton S. Hershey Medical Center

About this trial

The study objective of this project is to examine the mechanisms of the venous distension reflex (VDR) in humans. We hypothesize that COX blockade with ketorolac tromethamine, an intravenous NSAID, will attenuate the muscle sympathetic nerve activity (MSNA) response to limb venous distension. To gain further insight into whether the COX byproducts directly stimulate chemically-sensitive afferents, or enable venodilation and indirectly evoke afferent stimulation, we will measure vein size using 3T MRI during venous distention with and without ketorolac infusions.

Eligibility criteria

Qualifiers

Are capable of giving informed consent

Are any race or ethnicity

Are fluent in written and spoken English

Have a satisfactory history and physical exam to meet inclusion/

Disqualifiers

Are free of acute or chronic medical conditions

Are 21 - 35 years of age (inclusive)

Weigh over 50 kg

Are less than 21 or over 35 years of age

Trial design

Treatments tested in this trial

  • Wrist-to-elbow (W-E) occlusion
  • ketorolac tromethamine
  • saline control

Treatment groups

18 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Milton S. Hershey Medical Center

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator